1. Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD).
- Author
-
Matsukuma, Karen E, Wei, Dongguang, Sun, Kai, Ramsamooj, Rajendra, and Chen, Mingyi
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Immunology ,Transplantation ,Rare Diseases ,Digestive Diseases ,Liver Disease ,Cancer ,Development of treatments and therapeutic interventions ,5.2 Cellular and gene therapies ,Aetiology ,2.1 Biological and endogenous factors ,Hematopoietic cell transplantation ,graft versus host disease ,hepatic lymphoma ,drug-induced liver injury ,veno-occlusive hepatic disease ,post-transplant lymphoproliferative disorder ,immunotherapy ,Clinical sciences ,Oncology and carcinogenesis - Abstract
Graft versus host disease (GVHD) is a common complication following allogeneic hematopoietic cell transplantation (HCT) that typically manifests as injury to the skin, gastrointestinal mucosa, and liver. In some cases, hepatic GVHD may be histologically indistinguishable from other disorders such as infection and drug-induced liver injury (DILI). Additionally, clinical signs and symptoms are frequently confounded by the superimposed effects of pretransplant chemoradiotherapy, immunotherapy (IT) (targeted to the underlying malignancy), GVHD prophylaxis, and infection. Thus, careful attention to and correlation with clinical findings, laboratory values, and histologic features is essential for diagnosis. This review, aimed at the practicing pathologist, will discuss current clinical and histologic criteria for GVHD, the approach to diagnosis of hepatic GVHD, and features helpful for distinguishing it from other entities in the differential diagnosis.
- Published
- 2016